Rechallenge of drugs in the era of targeted therapy
- PMID: 24140185
- DOI: 10.1016/S1470-2045(13)70494-7
Rechallenge of drugs in the era of targeted therapy
Comment on
-
Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial.Lancet Oncol. 2013 Nov;14(12):1175-82. doi: 10.1016/S1470-2045(13)70453-4. Epub 2013 Oct 18. Lancet Oncol. 2013. PMID: 24140183 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
